Details for 2013703243

Up to date per 22.04.2026

Actions

Title / Product Name

FORMULIERUNGEN VON 3-(6-(1-(2.2-DIFLUORBENZO[D][1,3]DIOXOL-5-YL)-CYCLOPROPANCARBOXAMID)-3-METHYLPYRIDIN-2-YL)BENZOESÄURE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2013703243

EP Publication Number

2806859

E-Number

1132611

Language

PCT Number

US13023100

Publication Date

03.12.2014 A

15.05.2019 B1

Registration Date

15.05.2019

AT Publication Date

15.05.2019

Application Date

25.01.2013

Registration Number

Priorities

25.01.2012

201261590479 P

24.05.2012

201261651218 P

22.08.2012

201261691898 P

02.10.2012

201261708691 P

IPC

A61K 9/16 20060101AFI20130813BHEP

Maximum Duration of Protection

25.01.2033

Owner

Vertex Pharmaceuticals Incorporated50 Northern Avenue Boston, MA 02210US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

VERWIJIS, Marinus, Jacobus4 Carter Drive Framingham, MA 01701US

Information about Fees